Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling
- PMID: 2788171
- DOI: 10.1210/jcem-69-3-523
Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling
Abstract
To test the hypothesis that the reduction in gonadal function can lead to bone mass loss, a group of 12 men who had undergone bilateral orchidectomy at the age of 28.2 +/- 6.8 yr was evaluated. A progressive loss of the lumbar bone density was observed as a function of time after orchidectomy. Both the biochemical indices of bone resorption (urinary hydroxyproline/creatinine ratio and plasma tartrate-resistant acid phosphatase) and bone formation (serum osteocalcin and bone isoenzyme of alkaline phosphatase) were significantly increased in the patients compared with healthy controls. A positive correlation was found between urinary hydroxyproline excretion and percent change in spinal bone mineral density per yr. Because of this increase in the biochemically indicated bone resorption, nine of the patients were studied again after 1-3 yr and were thereafter treated with intranasal calcitonin. Urinary hydroxyproline excretion normalized after 3 months of treatment, and a significant decrease, but not to normal levels, was also observed in the mean values for the other biochemical indices of bone remodeling. Thus, testosterone deficiency, like estrogen deficiency, is associated with accelerated bone loss. The increase in osteoresorption was partially corrected by calcitonin treatment.
Similar articles
-
Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.J Bone Miner Res. 1989 Apr;4(2):193-8. doi: 10.1002/jbmr.5650040210. J Bone Miner Res. 1989. PMID: 2786321
-
Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.J Clin Endocrinol Metab. 1987 May;64(5):1079-82. doi: 10.1210/jcem-64-5-1079. J Clin Endocrinol Metab. 1987. PMID: 3031119
-
[Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].Cas Lek Cesk. 1997 Apr 16;136(8):242-8. Cas Lek Cesk. 1997. PMID: 9264868 Clinical Trial. Czech.
-
An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.J Clin Invest. 1993 Mar;91(3):1138-48. doi: 10.1172/JCI116273. J Clin Invest. 1993. PMID: 8450043 Free PMC article. Clinical Trial.
-
[Calcitonin].Rev Med Liege. 1996 Jan;51(1):116-9. Rev Med Liege. 1996. PMID: 8701121 Review. French. No abstract available.
Cited by
-
Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents.Urol Res. 1991;19(1):39-44. doi: 10.1007/BF00294020. Urol Res. 1991. PMID: 1851347
-
Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen.J Bone Miner Res. 2019 Mar;34(3):447-454. doi: 10.1002/jbmr.3612. Epub 2018 Dec 7. J Bone Miner Res. 2019. PMID: 30537188 Free PMC article.
-
Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men.Bone. 2007 Apr;40(4):913-8. doi: 10.1016/j.bone.2006.10.016. Epub 2006 Dec 8. Bone. 2007. PMID: 17157573 Free PMC article.
-
Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management.Drugs Aging. 1998 Dec;13(6):421-34. doi: 10.2165/00002512-199813060-00002. Drugs Aging. 1998. PMID: 9883398 Review.
-
Aromatization of androgens is important for skeletal maintenance of aged male rats.Calcif Tissue Int. 1996 Sep;59(3):179-83. doi: 10.1007/s002239900106. Calcif Tissue Int. 1996. PMID: 8694895
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources